ofloxacin has been researched along with riboflavin in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Arra, GS; Arutla, S; Krishna, DR; Prabhakar, CM | 1 |
Balidis, MO; Mangioris, GF; Papadopoulos, NT; Papadopoulou, DN; Poulas, JL; Seiler, T | 1 |
De Smet, J; Frueh, BE; Stary, J; Tappeiner, C; Thormann, W; Tschopp, M; Van Bocxlaer, J | 1 |
Hafezi, F | 1 |
Ammermann, C; Cursiefen, C; Hermann, M | 1 |
Godefrooij, DA; Hendriks, I; Mensink, MO; Soeters, N; Wisse, RPL | 1 |
1 review(s) available for ofloxacin and riboflavin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 other study(ies) available for ofloxacin and riboflavin
Article | Year |
---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Pro- and anti-oxidant effects of some antileprotic drugs in vitro and their influence on super oxide dismutase activity.
Topics: Antioxidants; Clofazimine; Dapsone; Dianisidine; Leprostatic Agents; Ofloxacin; Reactive Oxygen Species; Riboflavin; Rifampin; Superoxide Dismutase; Superoxides | 1998 |
Corneal infiltrates after corneal collagen cross-linking.
Topics: Adult; Collagen; Corneal Diseases; Corneal Stroma; Cross-Linking Reagents; Drug Therapy, Combination; Female; Humans; Keratoconus; Ofloxacin; Photosensitizing Agents; Postoperative Complications; Riboflavin; Tobramycin; Ultraviolet Rays | 2010 |
Impact of corneal cross-linking on drug penetration in an ex vivo porcine eye model.
Topics: Administration, Topical; Animals; Anterior Chamber; Anti-Bacterial Agents; Antifungal Agents; Aqueous Humor; Cornea; Models, Animal; Ofloxacin; Photosensitizing Agents; Pyrimidines; Random Allocation; Riboflavin; Swine; Triazoles; Ultraviolet Rays; Voriconazole | 2012 |
Significant visual increase following infectious keratitis after collagen cross-linking.
Topics: Anti-Bacterial Agents; Collagen; Corneal Stroma; Corneal Topography; Corneal Ulcer; Cross-Linking Reagents; Eye Infections, Bacterial; Humans; Keratoconus; Male; Microscopy, Confocal; Ofloxacin; Photosensitizing Agents; Postoperative Complications; Riboflavin; Staphylococcal Infections; Ultraviolet Rays; Vision Disorders; Visual Acuity; Young Adult | 2012 |
[Corneal cross-linking in microbial keratitis to prevent à chaud keratoplasty: a retrospective case series].
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial Infections; Biological Dressings; Combined Modality Therapy; Contact Lenses; Corneal Ulcer; Cross-Linking Reagents; Cryosurgery; Dexamethasone; Female; Humans; Keratitis; Keratoplasty, Penetrating; Male; Middle Aged; Mycoses; Ofloxacin; Photochemotherapy; Retrospective Studies; Riboflavin | 2014 |
Prospective 3-arm study on pain and epithelial healing after corneal crosslinking.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bandages; Collagen; Contact Lenses; Corneal Stroma; Cross-Linking Reagents; Epithelium, Corneal; Eye Pain; Female; Humans; Keratoconus; Male; Middle Aged; Ofloxacin; Pain Measurement; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Riboflavin; Ultraviolet Rays; Visual Acuity; Wound Healing; Young Adult | 2020 |